Cargando…

Haploinsufficiency Interactions of RALBP1 and TP53 in Carcinogenesis

Detalles Bibliográficos
Autor principal:	Awasthi, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827952/ https://www.ncbi.nlm.nih.gov/pubmed/33445456 http://dx.doi.org/10.3390/cancers13020255

Ejemplares similares

Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis
por: Singh, Sharda P., et al.
Publicado: (2021)

RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
por: Awasthi, Sanjay, et al.
Publicado: (2021)

PIN3 duplication may be partially responsible for TP53 haploinsufficiency
por: Winiecka-Klimek, Marta, et al.
Publicado: (2014)

Alterations of the TP53 Gene in Gastric and Esophageal Carcinogenesis
por: Bellini, Marilanda Ferreira, et al.
Publicado: (2012)

RalA and RalBP1 regulate mitochondrial fission at mitosis
por: Kashatus, David F., et al.
Publicado: (2011)

Identification and Characterization of the RLIP/RALBP1 Interacting Protein Xreps1 in Xenopus laevis Early Development
por: Boissel, Laurent, et al.
Publicado: (2012)

Regulation of cargo exocytosis by a Reps1-Ralbp1-RalA module
por: Wang, Shifeng, et al.
Publicado: (2023)

Environmental impact on carcinogenesis under BRCA1 haploinsufficiency
por: Toyokuni, Shinya, et al.
Publicado: (2023)

KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

Rlip depletion prevents spontaneous neoplasia in TP53 null mice
por: Awasthi, Sanjay, et al.
Publicado: (2018)

TP53 and MTOR crosstalk to regulate cellular senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2010)

Porcine model elucidates function of p53 isoform in carcinogenesis and reveals novel circTP53 RNA
por: Niu, Guanglin, et al.
Publicado: (2021)

Regulated RalBP1 Binding to RalA and PSD-95 Controls AMPA Receptor Endocytosis and LTD
por: Han, Kihoon, et al.
Publicado: (2009)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Tp53 Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis
por: Wu, Wei, et al.
Publicado: (2018)

RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration
por: Goldfinger, Lawrence E., et al.
Publicado: (2006)

Modeling the prevalent germline TP53 R337H mutation in mouse
por: Park, Ji-Hoon, et al.
Publicado: (2019)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Redox-sensitive TP53INP1 SUMOylation as an oxidative stress sensor to activate TP53
por: Bonacci, Thomas, et al.
Publicado: (2014)

Tp53 haploinsufficiency is involved in hotspot mutations and cytoskeletal remodeling in gefitinib-induced drug-resistant EGFR(L858R)-lung cancer mice
por: Wang, Yi-Shiang, et al.
Publicado: (2023)

Treatment selection with organoids in an EGFRm + TP53m stage IA1 patient with recurrence after radical surgery
por: Yamauchi, Yoshikane, et al.
Publicado: (2022)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion
por: Guo, Alvin Kunyao, et al.
Publicado: (2020)

Interaction between the microbiome and TP53 in human lung cancer
por: Greathouse, K. Leigh, et al.
Publicado: (2018)

TP53 mutations, expression and interaction networks in human cancers
por: Wang, Xiaosheng, et al.
Publicado: (2016)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells
por: Bennani-Baiti, Barbara, et al.
Publicado: (2015)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

The impact of chemotherapeutic drugs on the CYP1A1-catalysed metabolism of the environmental carcinogen benzo[a]pyrene: Effects in human colorectal HCT116 TP53(+/+), TP53(+/−) and TP53(−/−) cells
por: Willis, Alexandra J., et al.
Publicado: (2018)

BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance
por: Kong, Yingyi, et al.
Publicado: (2022)

The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development
por: Iordanishvili, Saba, et al.
Publicado: (2023)

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
por: Yabe, Mariko, et al.
Publicado: (2021)

TP53_PROF: a machine learning model to predict impact of missense mutations in TP53
por: Ben-Cohen, Gil, et al.
Publicado: (2022)

Synthetic lethality between TP53 and ENDOD1
por: Tang, Zizhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n5vg9dci1epblb4p1kae2u53tj